Independence Bank of Kentucky’s Arcturus Therapeutics ARCT Stock Holding History

Independence Bank of Kentucky’s Portfolio ARCT Stock Details ARCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-607	Closed	-$3K	–	335
2018 Q4	$3K	Hold	607	–	–	﹤0.01%	317
2018 Q3	$5K	Buy	+607	New	+$5.05K	﹤0.01%	307

Other funds holding ARCT

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Creative Planning

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $385M AUM 31.7% 1-Year Est. Return

Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

Prelude Capital Management New York $1.31B AUM 62.02% 1-Year Est. Return

Independence Bank of Kentucky's ARCT Position: Q1 2019 in Review

Independence Bank of Kentucky sold out of Arcturus Therapeutics (ARCT) in Q1 2019, closing a stake of 607 shares — an estimated $3K sold.

Independence Bank of Kentucky first reported a position in ARCT in Q3 2018 and held it in 2 quarters. The position peaked at $5K in Q3 2018. 19 funds tracked by Wall St. Rank hold ARCT as of Q1 2019.

Independence Bank of Kentucky reported no remaining Arcturus Therapeutics position as of Q1 2019 after selling out during the quarter.
Independence Bank of Kentucky sold 607 Arcturus Therapeutics shares in Q1 2019, an estimated $3K.
Independence Bank of Kentucky first reported a position in Arcturus Therapeutics in Q3 2018 and held it in 2 quarters.
Independence Bank of Kentucky's Arcturus Therapeutics position peaked at $5K in Q3 2018.
19 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2019.

Based on Independence Bank of Kentucky's 13F filing for Q1 2019, filed 29 Apr 2019.